Today’s clinical trials increasingly turn to third party data sources to collect study data. Electronic data capture (EDC) accounts for only 20-40 percent of all clinical data collected, which requires an innovative data management team to ensure transparency, data integrity and quality of your data.
The IQVIA Clinical Data Repository (CDR) ingests, integrates and standardizes data to drive downstream processes such as Real-Time Data Cleaning, Virtual Trials, Centralized Monitoring and machine learning. Because we understand your data needs to go beyond numbers to become what you really need – insights.
From building your database to locking it down, IQVIA provides a data management model where EDC and third party data are acquired and cleaned in real-time – providing faster decision-making, better outcomes and alerting sites and patients to issues.
Our clinical data management teams produce results that are verified at the source, delivering the transparency, integrity, accountability, speed, and accuracy you need.
IQVIA offers comprehensive data management solutions featuring full service, stand-alone and functional outsourcing models with experience in all therapeutic areas and all phases of clinical trials. With more than 3,000 CDM employees on five continents, you get the global resourcing you need, where you need it, with follow-the-sun coverage.
Whether as part of a full-service engagement or in a functional service provider (FSP) partnership, our methods foster high efficiencies, allow for early problem solving, and reduce oversight time.
At IQVIA, we integrate our data management, biostatistics and medical writing teams early in the clinical development process to provide expended value to our partners.
Getting the right outcomes from your clinical trials is all about the data and insights they provide. Biostatistics in clinical trials isn’t just a necessity, it can be a real competitive advantage.
Create transparency in your regulatory documents with a range of medical writing services that deliver quality and timeliness throughout your product development lifecycle.
Enhance patient safety and study quality by using data, analytics, and technology to monitor patient, site, and study performance with risk-based and centralized monitoring.
The value of data is derived from it being accurate and current. Integrating data management with biostatistics and medical writing has resulted in